<< Read Full Article
<< Read Full Article
Feraheme -- approved at last.
The injectable iron replacement therapy from AMAG Pharmaceuticals(AMAG Quote) was granted final marketing approval by U.S. regulators Tuesday night, ending a long-delayed process begun in December 2007.
Shares of AMAG were up 3.4% to $56.50 in recent trading. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,424.42 | 1,108.52 | 2,198.64 | 34.52 |
Oil *
76.78
|
|
UP
35.52
|
UP
2.54
|
UP
4.29
|
DOWN
0.31
|
10 Yr
3.45%
SPDR Gold
111.85
|
|
+0.34%
|
+0.23%
|
+0.20%
|
-0.89%
|
Data delayed 20 minutes |


Connect with TheStreet